Final report of outcomes from the National Consensus Conference for Vaccine-Preventable Diseases in Canada, June 12-14, 2005 - Quebec City, Quebec.
D002170:Canada; D002644:Chickenpox / Q000517:prevention & control; D003140:Communicable Disease Control; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control; D008589:Meningococcal Infections / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000627:therapeutic use; D010567:Pertussis Vaccine / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D014481:United States; D014612:Vaccines / Q000627:therapeutic use*; D014917:Whooping Cough / Q000517:prevention & control
D007252:Influenza Vaccines; D022401:Meningococcal Vaccines; D010567:Pertussis Vaccine; D022242:Pneumococcal Vaccines; D014612:Vaccines